Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Osteoporosis 2Myelodysplastic Syndromes 2Multiple Myeloma 2Hematologic Neoplasms 2Spinal Cord Compression 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Paraproteinemias 1Ovarian Neoplasms 1Osteosarcoma 1Osteonecrosis 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Neoplastic Processes 1Neoplasms, Plasma Cell 1Neoplasms 1Neoplasm Metastasis 1Lymphoma, Non-Hodgkin 1Lymphoma 1Leukemia, Myeloid, Acute 1Leukemia 1Hodgkin Disease 1Hematologic Diseases 1Fractures, Bone 1Bone Neoplasms 1Bone Marrow Diseases 1Bone Diseases 1Blood Protein Disorders 1

Interventions

Zoledronic Acid 1Surveys and Questionnaires 1Range of Motion, Articular 1Interviews as Topic 1Functional Status 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Osteonecrosis × Zoledronic Acid × Other hematologic neoplasm × Clear all
NCT02632903 2018-08-22

Intravenous Zoledronic Acid for the Treatment of Osteoporosis and Osteonecrosis in Children With Leukemia: A Pilot Study

Children's Hospital of Eastern Ontario

Phase 2 Withdrawn
LymphoidOther hematologic neoplasm

Osteonecrosis, Osteoporosis, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡